Complementary & Alternative Medicine Use in HIV+ Latinos in the US-Mexico Border

The recruitment status of this study is unknown because the information has not been verified recently.
Verified March 2012 by University of California, San Diego.
Recruitment status was  Recruiting
Sponsor:
Collaborator:
Information provided by (Responsible Party):
Zuniga De Nuncio, Maria, University of California, San Diego
ClinicalTrials.gov Identifier:
NCT01152684
First received: June 25, 2010
Last updated: March 14, 2012
Last verified: March 2012
  Purpose

The goal of The investigators community-based participatory research study is to identify the nature and extent of complementary and alternative medicine (CAM) use among HIV-positive Latinos on the San Diego/Tijuana border. CAM use among US Latinos living with HIV is associated with delayed utilization of and poor adherence to antiretroviral therapies (ARVs) that may exacerbate health disparities in HIV care access and health outcomes. This study will lead to development of culturally-effective interventions to improve access and adherence to HIV care in Latinos who face health disparities. The investigators hypothesis is that greater use of CAM will be observed among HIV-positive Latinos who report a) crossing the U.S. border more frequently, and b) having migrated to Tijuana or San Diego (e.g. from southern Mexico). The investigators also hypothesize that compared to HIV-positive Latinos who report using herbal CAM, those who do not use herbal CAM are more likely to be receiving ARVs and report higher levels of adherence to ARVs; Compared to HIV-positive Latinos who do not attend religious services regularly, those who attend religious services regularly are more likely to be receiving ARV; Compared to HIV- positive Latinos who report experiencing HIV related stigma, those who do not report experiencing HIV-related stigma are significantly more likely to be receiving ARVs.


Condition
HIV Positive

Study Type: Observational
Study Design: Observational Model: Ecologic or Community
Time Perspective: Cross-Sectional
Official Title: Complementary & Alternative Care Behavior in HIV+ Latinos in the US-Mexico Border

Resource links provided by NLM:


Further study details as provided by University of California, San Diego:

Estimated Enrollment: 260
Study Start Date: September 2009
Estimated Study Completion Date: April 2012
Estimated Primary Completion Date: April 2012 (Final data collection date for primary outcome measure)
Groups/Cohorts
HIV-Positive Latinos living in San Diego or Tijuana
This is an exploratory study of Latinos living with HIV in the San Diego-Tijuana US-Mexico border region.

  Show Detailed Description

  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Sampling Method:   Non-Probability Sample
Study Population

The population will be selected from 2 locations: 1. San Diego: San Ysidro Health Center(SYHC) will serve as the recruitment site on the US side of the border. Latinos comprise >90% of SYHC's patient population. SYHC provides HIV primary medical care to over 400 HIV-positive individuals. SYHC's HIV-positive Latino patient population includes persons who may or may not be on ARVs and who participate in clinic services to varying degrees. Previous studies with HIV-positive patients at SYHC indicate cross-border mobility and bi-national care seeking behavior in this clinic population. 2.Tijuana: The Agencia Familiar Binacional (AFABI;Binational Health Agency) opened the first HIV medical and social services agency clinic in Tijuana. This clinic is in close proximity to the municipal health clinic, where a large number of HIV-positive cases are diagnosed, and is linked with other non-profit social services agencies for HIV-positive persons, many of whom face barriers to ARVs.

Criteria

Inclusion Criteria:

  • Latino
  • Speak English or Spanish or both
  • Lived in San Diego or Tijuana for at least 1 month in the last year
  • 18 years or older
  • HIV-positive or living with AIDS

Exclusion Criteria:

  • Non-Latino
  • Speak neither English nor Spanish
  • Have not lived in San Diego or Tijuana for at least 1 month in the last year
  • Under 18 years of age
  • Not HIV-positive or living with AIDS
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01152684

Contacts
Contact: Justine Kozo, MPH 619-681-0641 jkozo@ucsd.edu
Contact: Maria L Zúñiga, PhD 619-681-0689 mzuniga@ucsd.edu

Locations
United States, California
San Ysidro Health Center Recruiting
San Ysidro, California, United States, 92173
Contact: Justine Kozo, MPH         
Principal Investigator: Rosana Scolari, MPH         
Sponsors and Collaborators
Zuniga De Nuncio, Maria
Investigators
Principal Investigator: Maria L Zúñiga, PhD University of California, San Diego
  More Information

No publications provided

Responsible Party: Zuniga De Nuncio, Maria, Principal Investigator, University of California, San Diego
ClinicalTrials.gov Identifier: NCT01152684     History of Changes
Other Study ID Numbers: R21 AT004676-01A1, R21AT004676-01A1
Study First Received: June 25, 2010
Last Updated: March 14, 2012
Health Authority: United States: Federal Government

Keywords provided by University of California, San Diego:
CAM
HIV-Positive
Latinos
US-Mexico Border region
San Diego-Tijuana
Identify the nature and extent of complementary and alternative medicine use among HIV-positive Latinos in the US-Mexico border region

Additional relevant MeSH terms:
HIV Seropositivity
HIV Infections
Lentivirus Infections
Retroviridae Infections
RNA Virus Infections
Virus Diseases
Sexually Transmitted Diseases, Viral
Sexually Transmitted Diseases
Immunologic Deficiency Syndromes
Immune System Diseases

ClinicalTrials.gov processed this record on August 20, 2014